Market Access World USA 2012

The most comprehensive pharma market access forum in the US

Experts in market access, pricing and health policy will provide delegates with the most comprehensive review of the US health reform.

This event will examine new strategies to control drug costs and reduce budget deficits whilst widening patient access. You will hear a balanced discussion between industry and public, private sector payers.

• Keynote Speakers

Michael Anderson,Ted Buckley,Anita Burrell,Teresa DeLuca,Lida Etemad,Marcus Farbstein,Steve Feldman and many more.

Come to Market Access World USA 2012 to learn

• the impact of reimbursement models on market access

• how will CER differ from the EU HTA experience

• HTA agency policy and practice globally

• how the US economy will impact state Medicaid programs

• the impact of changing incentive structures

• the importance of risk sharing, value based pricing and pay for performance

• how to generate data specifically for payers in comparative effectiveness research

• how to overcome the challengers in the emerging markets of Latin America & Asia

Who should attend

• Health Policy

• Market Access

• Pricing & Reimbursement

• Health Economics/Outcomes

• HTA/Comparative Effectiveness

• Evidence Based Medicine

• Pharmacoeconomics

• Chief Pharmacy Officers

• Chief Medical Officers

• Marketing

• Medical Affairs

• Government, Payer & Stakeholder relations